Table 3 Complications between ePLN+ and sPLN+cohorts
LND Template | ||||
|---|---|---|---|---|
Variable | Overall N = 901 | ePLN+ n = 471 | sPLN+ n = 431 | P-value2 |
Any complication, n (%) | 76 (84%) | 39 (83%) | 37 (86%) | 0.69 |
Grade 2 + complications, n (%) | 64 (71%) | 31 (66%) | 33 (77%) | 0.26 |
Renal, n (%) | 11 (12%) | 7 (15%) | 4 (9%) | 0.42 |
Gastrointestinal, n (%) | 22 (24%) | 11 (23%) | 11 (26%) | 0.81 |
Cardiac, n (%) | 14 (16%) | 5 (11%) | 9 (21%) | 0.18 |
Pulmonary, n (%) | 9 (10%) | 3 (6%) | 6 (14%) | 0.30 |
Neurologic, n (%) | 5 (6%) | 2 (4%) | 3 (7%) | 0.67 |
Skin, n (%) | 0 (0%) | 0 (0%) | 0 (0%) | > 0.99 |
VTE, n (%) | 8 (9%) | 3 (6%) | 5 (12%) | 0.47 |
Infectious, n (%) | 35 (39%) | 18 (38%) | 17 (40%) | 0.90 |
Hematologic, n (%) | 17 (19%) | 11 (23%) | 6 (14%) | 0.25 |
Stoma, n (%) | 0 (0%) | 0 (0%) | 0 (0%) | > 0.99 |
Surgical site/wound, n (%) | 11 (12%) | 6 (13%) | 5 (12%) | 0.87 |
Genitourinary, n (%) | 14 (16%) | 9 (19%) | 5 (12%) | 0.33 |
Metabolic, n (%) | 10 (11%) | 7 (15%) | 3 (7%) | 0.32 |